ALINITY I HBSAG REAGENT KIT
Report
- Report Number
- 3008344661-2025-00172
- Event Type
- Malfunction
- Date Received
- December 8, 2025
- Date of Event
- November 19, 2025
- Report Date
- January 27, 2026
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- LOM
- UDI-DI
- 00380740130169
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE COMPLAINT INVESTIGATION INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TICKET TRENDING REVIEW, LABELING REVIEW, AND DEVICE HISTORY RECORD REVIEW. A REVIEW OF TRACKING AND TRENDING DID NOT IDENTIFY ANY TRENDS REGARDING THE COMMONALITIES FOR THE CURRENT ISSUE. A REVIEW IN THE CORRECTIVE AND PREVENTIVE ACTIONS (CAPA) SYSTEM DID NOT IDENTIFY ANY NONCONFORMANCES, POTENTIAL NONCONFORMANCES, OR DEVIATIONS ASSOCIATED WITH THE LIST NUMBER AND COMPLAINT ISSUE. LABELING WAS REVIEWED AND SUFFICIENTLY ADDRESSES SAFETY HAZARDS INCLUDING THE WEARING OF PERSONAL PROTECTIVE EQUIPMENT (PPE) AND SAFETY AWARENESS WHERE HAZARDS MAY EXIST. BASED ON THE INVESTIGATION, THE ALINITY I HBSAG CONTROLS, LIST NUMBER 08P08-10, WHICH IS USED FOR THE ALINITY I HBSAG ASSAY, IS PERFORMING AS INTENDED, NO SYSTEMIC ISSUE OR PRODUCT DEFICIENCY WAS IDENTIFIED.
AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 08P08 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 04P53, WITH 510K/PMA/BLA NUMBER P110029.
AFTER THE CUSTOMER PERFORMED AN ALINITY I HBSAG CONTROL TEST FOR THE ALINITY I HBSAG ASSAY, SOME CONTROL LIQUID SPLASHED ONTO THE CUSTOMER WHEN THEY WERE DISPOSING OF THE CONTROL SAMPLE. IT IS UNCLEAR IF THE LIQUID SPLASHED INTO THEIR EYES, HOWEVER THEY WERE NOT WEARING PROTECTIVE EYE WEAR. THE CUSTOMER WASHED THEIR EYES AND REPLACED THEIR CONTACT LENSES. THERE WAS NO MEDICAL INTERVENTION / TREATMENT REPORTED. THERE WAS NO FURTHER IMPACT TO PATIENT MANAGEMENT OR USER SAFETY REPORTED.
AFTER THE CUSTOMER PERFORMED AN ALINITY I HBSAG CONTROL TEST FOR THE ALINITY I HBSAG ASSAY, SOME CONTROL LIQUID SPLASHED ONTO THE CUSTOMER WHEN THEY WERE DISPOSING OF THE CONTROL SAMPLE. IT IS UNCLEAR IF THE LIQUID SPLASHED INTO THEIR EYES, HOWEVER THEY WERE NOT WEARING PROTECTIVE EYE WEAR. THE CUSTOMER WASHED THEIR EYES AND REPLACED THEIR CONTACT LENSES. THERE WAS NO MEDICAL INTERVENTION / TREATMENT REPORTED. THERE WAS NO FURTHER IMPACT TO PATIENT MANAGEMENT OR USER SAFETY REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 139648 | ALINITY I HBSAG REAGENT KIT | TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) | LOM | ABBOTT IRELAND DIAGNOSTICS DIVISION | 72550FZ00 | 00380740130169 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | ALNTY I HBS AG QUANT CT, (B)(6). |